caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1841256989

Randall Hrabko

General PracticeSebastopol, CAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
REFERRAL NETWORK

Where Randall Hrabko's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 15 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
ADVENTIST HEALTH CLEARLAKE HOSPITAL INC.137346
Ucsf Dermatopathology Service
Clinical Laboratory · San Francisco, CA
125374
ADVENTIST HEALTH CLEARLAKE HOSPITAL INC.86204
DOUGLAS, JERRY33106
William Duge
Diagnostic Radiology · Saint Helena, CA
2942
Geoffrey Horn
Diagnostic Radiology · Saint Helena, CA
2533
ST. JOSEPH HEALTH NORTHERN CALIFORNIA, LLC2447
Theresa Schmitz
Physician Assistant · Hidden Valley Lake, CA
1843
David Racker
Diagnostic Radiology · Saint Helena, CA
1620
SUTTER BAY HOSPITALS1334
Kimberly Fordham
Family Practice · Middletown, CA
1219
Andrew Schwartz
Family Practice · Rohnert Park, CA
1242
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
PRESCRIBING · PART D · 2024
Total Rx claims
12
Beneficiaries
—
Total drug cost
$35
Distinct drugs
1
Brand share
0.0%
Top prescribed drugs
Triamcinolone Acetonide12 claims
QUALITY · MIPS · 2024
Final MIPS score
84.8
Quality
96.3
Cost
54.4
Improvement activities
40.0
Promoting interop.
0.0
Payment adjustment
0.41%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.